Clinical management of relapse in type 1 autoimmune pancreatitis: a systematic review and meta-analysis. (PubMed, Am J Gastroenterol) - Oct 9, 2026 - "Maintenance therapy is associated with a lower relapse risk in type 1 AIP, with longer-term glucocorticoid therapy showing benefit in Asian cohorts. Relapse risk accumulates over time and predominantly involves the pancreatobiliary system. Rituximab may provide favorable outcomes for relapse treatment, but its comparative superiority remains uncertain because of low-certainty evidence."
Journal • Retrospective data • Diabetes • Immunology • Metabolic Disorders • Pancreatitis
|
|
Can Li; Chenxiao Liu; Chunhua Zhou; Duowu Zou; Henglong Li; Tianyi Che; Venkata Akshintala; Wanqian Xu; Xiaonan Shen; Yao Zhang; Yixiao Wang; Zonghao Liu
|